Anji Pharmaceuticals

Developer of peptides for treatment of hypercholesterolemia

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups12 employees language anjipharma.com

Innovation

11 patent families (10 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 2,390 times.

YearFilings
20174
20193
20203
20212
20223
20236
20245
20253

Investor mix

5 investors on record; lead investors include Viva Ventures Biotech Fund.

Investor typeCountShare
Venture capital480%
Private equity120%
Coming soon